Researchers from Helmholtz Munich and the Technical University of Munich have developed a novel method to track cancer treatment responses in individual cells—without the need for dyes or labels.

Gynecological clear cell cancers (CCCs), very aggressive forms of ovarian and endometrial malignancies, respond poorly to chemotherapy.  The low respo | Cancer ...

THURSDAY, Aug. 21 (HealthDay News) -- U.S. researchers have identified 170 more proteins to add to the 91 already known to be associated with programmed cell death, or apoptosis. They also ...

Programmed cell death pathways can be either lytic or non-lytic. During lytic cell death, the contents of a dying cell are released into the surrounding space as the cell’s membrane becomes damaged. 4 ...

How an unfolding protein can induce programmed cell death Date: July 6, 2021 Source: University of Groningen Summary: The death of cells is well regulated. If it occurs too much, it can cause ...

Phase Ib study of MEDI4736, a programmed cell death ligand-1 (PD-L1) antibody, in combination with tremelimumab, a cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) antibody, in patients (pts) with ...

Recent research on MCL-1, a critical protein that is an attractive target for cancer drug development, helps explain why some ...

AnaptysBio’s lead drug rosnilimab showed promise in RA, but lack of a Phase 3 plan and limited pipeline raise concerns. Find ...

Lam has studied the process at the heart of the enzyme's pivotal role in plant health—a phenomenon known as programmed cell death or cell suicide—for the past 30 years.

Gotistobart is a next-generation anti-cytotoxic T-lymphocyte-associated protein 4 antibody candidate in late-stage clinical development for various cancer indications.